using electrocardiographic recordings from 15,193 patients enrolled in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial. The interval to cardiac events was the primary end point. The researchers found that, after adjusting for …
Xuchang Hengsheng Pharmaceutical Co., Ltd.
Manidipine Hydrochloride main manufacturer in the world
using electrocardiographic recordings from 15,193 patients enrolled in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial. The interval to cardiac events was the primary end point. The researchers found that, after adjusting for …